The funding will allow 52North to move its products, including its Neutrocheck point-of-care device, toward commercialization.

The TarCET Kit offers a suite of sequencing panels covering a range of genetic conditions including metabolic disorders, infertility, and cardiovascular diseases.

Out of the 30 companies tracked by 360Dx, 13 saw their share prices increase, while 17 saw their stock prices decline.

The awards will support the development of US Food and Drug Administration-cleared tests for Marburg virus and Burkholderia pseudomallei infection.

Last week, readers were most interested in a story about Agilent changing two of its three business organizations to accelerate growth.

Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.

NEW YORK – Natera announced on Wednesday that its Prospera Lung test has received coverage from the US Centers for Medicare and Medicaid Services for single lung transplant patients in the ...

NEW YORK – Hong Kong-based genomic testing firm Prenetics on Wednesday announced that its Q3 revenues rose 59 percent year over year. The firm reported revenue of $7.8 million, up from $4.9 million in ...

NEW YORK – PixCell Medical on Wednesday said its point-of-care HemoScreen CBC analyzer has received certification under Europe's In Vitro Diagnostic Medical Device Regulation (IVDR). The Israeli firm ...

NEW YORK – With the recent approval of its human papillomavirus test for use with self-collected cervical swab samples, Becton Dickinson is embarking on a new implementation study with MD Anderson and ...